Skip to main content
. Author manuscript; available in PMC: 2022 Aug 1.
Published in final edited form as: Cancer Prev Res (Phila). 2021 Nov 8;15(2):129–138. doi: 10.1158/1940-6207.CAPR-21-0399

Fig. 2.

Fig. 2.

Subject randomization, withdrawals, and reported side effects. A total of 95 subjects were randomized to either daily placebo (n=28), 81 mg ASA (n=32), or 325 mg ASA (n=31) as indicated. There were 4 withdrawals from the placebo group. Shown are the numbers of subjects in each group who completed the study and the number (in parentheses) reporting various side effects.